VJVandana Jain

Vandana Jain

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vandana Jain has a total of 177 co-authors. Here are the top co-authors by number of shared publications:

  • Rajni Sharma

    Pediatric Endocrine Division, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India

    13 shared publications
  • Priyanka Gupta

    Pediatric Endocrinology Division, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India

    12 shared publications
  • Amit Kumar Satapathy

    Department of Pediatrics, All India Institute of Medical Sciences, Bhubaneswar, India

    8 shared publications
  • Brijesh Kumar

    Pediatric Endocrinology Division, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India

    7 shared publications
  • Anil Kumar

    Division of Pediatric Endocrinology All India Institute of Medical Sciences New Delhi India

    6 shared publications
  • Manisha Jana

    Department of Radiodiagnosis, All India Institute of Medical Sciences, New Delhi, India

    6 shared publications

Latest Publications

  • Multidisciplinary Care Model for Differences in Sex Development: An Implementation Research Study

    by Sukanya Priyadarshini, Ankesh Singh, Kaushal Kulkarni, Devendra Kumar Yadav, Rajesh Sagar, Rajni Sharma, Minu Bajpai, Vandana Jain

    Objective: To initiate a multidisciplinary care model for patients with differences in sex development (MD‐DSD), assess its implementation, and evaluate changes in perceived quality of care following implementation among parents and health‐care providers (HCPs). Design: Implementation research. Setting: Tertiary care Institute at New Delhi. Patients: Patients aged 0–22 years with DSD, receiving care in single‐specialty clinics at the Institute. Interventions: A core MD‐DSD team comprising specialists from Paediatric Endocrinology, Paediatric Surgery and Psychiatry was formed. Multidisciplinary clinics were conducted monthly, and board meetings for difficult cases were held bi‐monthly, with participation from all core and requisite allied specialties. Main Outcome Measures: The primary outcome was successful implementation of MD‐DSD clinics and board meetings, defined by representation from all three core specialties. Secondary outcomes included changes in the Perceived Quality‐of‐Care Questionnaire (PQCQ) scores (administered to parents at baseline and after attending two clinics, score range: 9‐45), and perceptions of participating HCPs at study completion. Results: Over 28 months, 28 clinics and 13 meetings were held. A total of 188 patients (46,XX DSD, 69; 46,XY DSD, 104; and sex chromosome DSD, 15) attended the MD‐DSD clinics; and 44 of these were also reviewed in MD‐DSD meetings, predominantly for concerns relating to gender of rearing and decision on surgical intervention. Participation from all core specialties was present in 26 (93%) clinics and 12 (92%) meetings. The PQCQ scores ( N = 79) improved from 32.2 ± 5.7 to 36.4 ± 4.5 ( p < 0.001), contributed chiefly by improved parent knowledge and attention to psychosocial needs. The participating HCPs ( N = 12/15) believed that the model was sustainable. Conclusions: The MD‐DSD care model was feasible and demonstrated favourable perceived sustainability, with improvement in the perceived quality of care reported by both parents and HCPs.

  • Congenital Adrenal Hyperplasia due to Proximal Steroidogenic Defects: A Single‐Centre Experience From New Delhi

    by Sukanya Priyadarshini, Priyanka Gupta, Avadhesh Verma, Rajni Sharma, Vandana Jain

    Background: Variants in STAR , encoding Steroidogenic Acute Regulatory (StAR) protein, and CYP11A1 , encoding the cholesterol Side‐Chain Cleavage (SCC) enzyme, result in proximal steroidogenic defects. These are classically described as presenting with neonatal‐onset primary adrenal insufficiency, with the additional finding of sex reversal in 46,XY newborns. However, the phenotypic spectrum is much wider. The present study aimed at describing the phenotypic heterogeneity and genotypes of patients with STAR and CYP11A1 variants followed up at a tertiary care centre in India. Methods: Hospital records of all patients with variants in STAR and CYP11A1 who were followed up at the Paediatric Endocrinology division of a tertiary care hospital between January 2018 and January 2026 were reviewed for clinical details and genotypes. Results: Variants in STAR and CYP11A1 were identified in four patients each. Among patients with variants in STAR , two had homozygous pathogenic/likely pathogenic variants, while two had two heterozygous variants; phase undetermined [of which one was a variant of uncertain significance (VUS)]. The presenting features were salt‐wasting crisis ( n = 3, at ages 2 years, 5 years and Day 15, respectively) and atypical genitalia ( n = 1). Among patients with variants in CYP11A1 , one had two heterozygous variants; phase undetermined (of which one was a VUS), while three had homozygous VUSs. The presentation ranged from adrenal crisis ( n = 1, at 3.8 years) and salt‐wasting crisis ( n = 1, at 10 months) to progressive hyperpigmentation ( n = 2, at ages 6.5 years and 21.9 years, respectively). None of the patients had genital ambiguity, while one patient presented with 46,XY sex reversal. Conclusion: The present study highlights the wide phenotypic spectrum associated with STAR and CYP11A1 variants, ranging from classical neonatal salt‐wasting crisis with 46,XY sex reversal, to isolated primary adrenal insufficiency, or isolated undervirilisation, with later emergence of gluco‐ and mineralocorticoid deficiency.

  • Body Composition of Preschool Children Born Term Versus Late-Preterm: A Follow-Up Study of Two Birth Cohorts

    by Dilip Kumar, Priyanka Gupta, Brijesh Kumar, Monika Singh, Vandana Jain

    Objective To compare the body composition of term- versus late-preterm-born children at preschool age. Methods Anthropometry, fat mass (FM), FM%, fat mass index (FMI), fat-free mass (FFM), and fat-free mass index (FFMI) using air displacement plethysmography were assessed in 3–5-year-old children from two birth cohorts (term and late-preterm). Only children who were appropriate for gestational age were included. Children with any chronic illness or neurodevelopmental disability were excluded. Results Twenty-five term-born and 22 late-preterm-born children were enrolled. Their mean (SD) birth weight, gestational age, and current age were 3.0 (0.2) versus 2.4 (0.3) kg, 38.6 (0.6) versus 35.2 (0.8) weeks, and 47.7 (5.0) versus 45.1 (3.6) months, respectively. At birth, the preterm-born infants had lower FM, FFM, FMI, as well as FFMI compared to term-born infants. Their height-for-age Z-score [-0.9 (-1.7, -0.5) vs. − 1.0 (− 1.7, − 0.4), P = 0.773], body mass index-for-age Z-score [− 0.6 (− 1.3, 0.6) vs. − 0.8 (− 1.3, − 0.0), P = 0.586], FM% [18.6 (9.7) vs. 17.5 (8.4), P = 0.709], and FFMI [12.1 (1.3) vs. 11.9 (1.1) kg/m2, P = 0.645] at 3–5 years were comparable. The change in weight-for-age Z-score from birth to the current age correlated positively with FM% in both groups. Conclusions Compared to the term group, the late-preterm group was smaller in all anthropometric parameters and had lower FMI as well as FFMI at birth; however, the anthropometric parameters and body composition were comparable at preschool age.


  • Clinical Characterization and Molecular Profiling by Targeted Next‐Generation Sequencing in a Large Indian Cohort With 46,XY Differences in Sex Development

    by Vandana Jain, Sukanya Priyadarshini, Rajni Sharma, Anil Kumar, Shilpa Sharma, Palany Raghupathy, Ralf Werner, Olaf Hiort, Mohammed Faruq

    Background: 46,XY differences in sex development (DSD) comprise a heterogeneous group of conditions. Molecular diagnosis guides management by giving insights into the pathophysiology of sex development, reproduction, tumour formation and extragenital issues. Methods: Children with 46,XY DSD from a tertiary hospital in India underwent comprehensive assessment and stepwise genetic testing. Targeted testing for SRD5A2 and AR was performed in cases with suspected 5α‐reductase type 2 (5αR2) deficiency/androgen insensitivity syndrome (AIS). For all other patients, and those without variants in SRD5A2 or AR on Sanger sequencing, NGS using a targeted 155‐gene panel was performed. Longitudinal clinical data was also collated. Results: One hundred and forty‐seven children with 46,XY DSD with a median (interquartile range) age of 3.8 (1.4, 10.6) years were enrolled. Provisional clinical diagnoses were 5αR2 deficiency/AIS ( n = 83, 56.5%), gonadal dysgenesis ( n = 31, 21%), testosterone biosynthetic defect ( n = 11, 7.5%) and others ( n = 22, 15%) based on clinical, biochemical and radiological assessment. Sequential single gene testing for SRD5A2 and AR performed in 75 patients with a clinical diagnosis of 5αR2 deficiency/AIS identified pathogenic/likely pathogenic variants in 44 subjects. NGS in the remaining 103 children revealed pathogenic/likely pathogenic variants in 20 subjects across 12 genes, with NR5A1 being the most frequent (7/103). Four subjects had variants of uncertain significance (VUS) deemed possibly pathogenic due to good genotype‐phenotype correlation. Overall, 68/147 (46%) achieved a molecular diagnosis in this cohort. Conclusion: Sanger sequencing followed by NGS could provide molecular diagnosis in 46% of this Indian cohort with 46,XY DSD . SRD5A2 , AR and NR5A1 were the most frequently implicated genes.


  • Body Composition of Healthy Term Indian Newborns by Air Displacement Plethysmography: A Cross-Sectional Study

    by Asma Shaheen Tak, Priyanka Gupta, Ramesh Agarwal, Vandana Jain

    Objective To evaluate the body composition of Indian newborns using air displacement plethysmography (ADP) and assess the correlation between fat mass percentage (FM%) and anthropometric parameters. Methods A cross-sectional study at a single centre in New Delhi, India, assessed the body composition of singleton, term, healthy newborns at 24–72 h of life by ADP technique using Peapod and described as FM%, fat mass index (FMI) and fat-free mass index (FFMI). Comprehensive anthropometry (head, arm, abdomen and chest circumferences; 5-site skinfold thicknesses) and parental anthropometry was also performed in a subset. Anthropometric data were converted to Z-scores using WHO Anthro software. Results One hundred and forty-five newborns (73 males) were evaluated. The mean (SD) birthweight was 2882 (305) g and FM% was 7.9 (3.3). FM% correlated positively with birthweight (r = 0.27, P < 0.01); mean FM% being 6.8 (3.6), 8.0 (2.9) and 8.8 (3.4), respectively, in newborns with birthweight < 2700 g (n = 41), 2700–2999 g (n = 52) and ≥ 3000 g (n = 52) (P = 0.015), respectively. Higher maternal last trimester body mass index (BMI) was associated with higher FM% (r = 0.30, P = 0.009). Gestational age correlated with birthweight (r = 0.30, P = 0.003), and FFMI (r = 0.34, P < 0.001), but not with FM% or FMI. Maternal gestational weight gain, and dairy intake correlated with birthweight (r = 0.26, P = 0.012, and r = 0.21, P = 0.040, respectively) but not with neonatal body composition. BMI and sum of SFT (subscapular, triceps and suprailiac) showed a modest correlation with FM% (r = 0.42 and r = 0.38, P < 0.001). Conclusion Indian newborns do not demonstrate a thin–fat phenotype. FM% measured using ADP is lower than that reported in comparator populations and shows a positive association with birth weight.


  • Open Access

    Peripheral Precocious Puberty in a Girl with hCG-Secreting Suprasellar Germ Cell Tumor

    by Sukanya Priyadarshini, Priyanka Gupta, Vandana Jain


  • Open Access

    Catch-up growth in low birth weight infants

    by Priyanka Gupta, Praveen George Paul, Vandana Jain

    Catch-up growth (CUG) is a broad term that defines the recovery process of growth in children following a transient period of reduced growth, such as following illness or starvation. Currently, the term is most often used in the context of the upward growth trajectory seen in the initial months of life in babies born low birth weight (LBW) due to prematurity and/or intrauterine growth restriction. CUG decreases the prevalence of undernutrition and infection during early life and improves neurocognitive outcomes in preterm infants. However, the flip side, especially if the catch-up is excessive, can be an increased risk of obesity and metabolic syndrome in later life, and therefore, caution is needed while planning the nutritional strategies for infants born with LBW. In this review, we discuss the current definitions of CUG, benefits, adverse effects and their pathophysiology, and few proposed strategies for monitoring growth in infants born LBW to ensure an optimal CUG.